Carbonic anhydrase inhibitors: Design, synthesis, kinetic, docking and molecular dynamics analysis of novel glycine and phenylalanine sulfonamide derivatives

Fidan I., Salmas R. E., ARSLAN M., ŞENTÜRK M., DURDAĞI S., EKİNCİ D., ...Daha Fazla

BIOORGANIC & MEDICINAL CHEMISTRY, cilt.23, sa.23, ss.7353-7358, 2015 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 23 Sayı: 23
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1016/j.bmc.2015.10.009
  • Dergi Adı: BIOORGANIC & MEDICINAL CHEMISTRY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.7353-7358
  • Anahtar Kelimeler: Carbonic anhydrase, Glycine, Phenylalanine, Sulfonamide, Docking, Enzyme inhibitor, THERAPEUTIC APPLICATIONS, X-RAY, ISOENZYMES, BINDING, SITE
  • Ondokuz Mayıs Üniversitesi Adresli: Evet

Özet

The inhibition of two human cytosolic carbonic anhydrase isozymes I and II, with some novel glycine and phenylalanine sulfonamide derivatives were investigated. Newly synthesized compounds G1-4 and P1-4 showed effective inhibition profiles with K-I values in the range of 14.66-315 mu M for hCA I and of 18.31-143.8 mu M against hCA II, respectively. In order to investigate the binding mechanisms of these inhibitors, in silico docking studies were applied. Atomistic molecular dynamic simulations were performed for docking poses which utilize to illustrate the inhibition mechanism of used inhibitors into active site of CAII. These sulfonamide containing compounds generally were competitive inhibitors with 4-nitro-phenylacetate as substrate. Some investigated compounds here showed effective hCA II inhibitory effects, in the same range as the clinically used sulfonamide, sulfanilamide or mafenide and might be used as leads for generating enzyme inhibitors possibly targeting other CA isoforms which have not been yet assayed for their interactions with such agents. (C) 2015 Elsevier Ltd. All rights reserved.